Please fill out the form and we will be in touch with you shortly.

Williams Law Group
137 Public Square
Lebanon, TN 37087
local: 615-444-2900
toll free: 866-820-4457
fax: 615-444-6516

Nashville City Center
511 Union Street, Suite 1850
Nashville, TN 37219
local: 615-313-3999

Every day, Americans put their health and well–being in the hands of the pharmaceutical industry and the medical profession. Sometimes, however, a drug manufacturer knows that a drug could endanger consumers, but fails to warn physicians or the public of the serious health risks associated with its use. Although the federal Food and Drug Administration (FDA) oversees the drug manufacturing process, the agency’s approval of a specific drug does not always guarantee that it is safe. In fact, the FDA may pull a harmful drug off the market after it has already caused significant damage to patients.

The New England Journal of Medicine has released the results from 42 studies
involving 15,560 diabetes patients who were prescribed AVANDIA.  Patients getting Avandia were 43 percent more likely to have a heart attack.
The study also suggested a trend toward higher death rates in the Avandia group.  Avandia (rosiglitazone) is manufactured by drug maker GlaxoSmithKline,
and is one of the most popular pharmaceuticals for the treatment of Type 2 Diabetes.

FOSAMAX (alendronate sodium) is mainly used to prevent and reverse bone loss, called osteoporosis. However, the drug may cause severe decay of the jaw bone or jaw osteonecrosis. This disorder causes loose teeth and jaw pain. At present, there is no cure for jaw osteonecrosis.

Millions of Americans, most of them teenagers and young adults, have taken the powerful drug ACCUTANE.  It is undisputed that the drug worked very well for acne.  Over 500,000 perscriptions for the drug were written last year.  However, over 500 individules have filed suit against the drug maker Hoffman-La Roche Inc. claiming Accutane's link to their serious gastrointestinal diseases of ulcerative colitis or Crohn's disease.  These conditions are characterized by abdominal pain, diarrhea and weight loss.  Internal documents discovered in this litigation revealed that the company has long known of the danger but downplayed the drugs link to the disease.

HRT, or Hormone Replacement Therapy, is a therapy involving a series of drugs used to treat the adverse symptoms involved with menopause. In recent years, HRT treatment has been medically linked to increased risk to Breast Cancer. Some of the treatments involved in HRT include Premarin, Prempro (Wyeth) and Provera (Pfizer). In recent studies have shown that woman who take these treatments are at higher risk for Breast Cancer, Ovarian Cancer, Non-Hodgkins Lymphoma, Heart Attack, Stroke and Blood Clots.

The arthritis drugs CELEBREX and BEXTRA may increase the risk of heart attacks and strokes. Taking Bextra was particularly dangerous for patients who had already undergone heart bypass surgery. Bextra users had the added risk of developing a severe allergic skin reaction known as Stevens–Johnson syndrome. This disorder of the immune system causes painful blistering of the skin and mucous membranes. Celebrex and Bextra are related to VIOXX, which was withdrawn from the market. Bextra was withdrawn from the market in April, 2005, but Celebrex is still available.

According to the FDA, women who use  the ORTHO EVRA PATCH are exposed to 60% more estrogen than those who use a birth control pill.  Compared with women who use birth control pills, these Ortho Patch users have twice the risk of developing blood clots, according to some studies. These blood clots can cause deep vein thrombosis (DVT); pulmonary embolisms;  heart attacks; strokes or even death.  

Newborns whose mothers received RhoGAM during pregnancy to decrease birth complications may have been exposed to mercury. Mercury has been linked to autism and nervous disorders. Until 2001, RhoGAM included the preservative thimerosal, which contains mercury. Although the RhoGAM package insert mentioned thimerosal, it did not provide any warnings about the effects of mercury on mothers or their babies. Thimerosal has also been used in various vaccines.

The antibiotic TEQUIN has caused severe blood glucose changes in some patients, leading to hospitalizations and deaths. One Canadian study found that Tequin users were almost 17 times more likely to have a high blood sugar (hyperglycemic) episode than were patients taking other antibiotics such as erythromycin. They had four times the odds of having a low blood sugar (hypoglycemic) episode. Tequin is prescribed for bronchitis, pneumonia, gonorrhea, and lung, skin, kidney and urinary tract infections. Its manufacturer, Bristol–Myers had $150 million in sales for the drug in 2005. However, the company stopped manufacturing Tequin in May, 2006, citing business reasons.

The Composix KUGEL MESH PATCH is manufactured by Davol, Inc. (parent company: C.R. Bard, Inc.) and used in hernia surgery repair. Problems with the "memory recoil ring" that opens the Composix Kugel Mesh Patch can break under the stress of placement of the large sized products in the intra-abdominal space. This can lead to bowel perforations and/or chronic intestinal fistulae, or abnormal connections or passageways between the intestines and other organs.

If you or a family member thinks damage has been caused by a dangerous drug please contact the dangerous drug attorneys at Williams Law Group.